CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-16 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +24,832 | 238,332 | ||
| 2025-01-16 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit | −13,696 | 0 | ||
| 2025-01-16 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +9,130 | 126,127 | ||
| 2025-01-16 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +29,798 | 155,925 | ||
| 2025-01-16 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +9,620 | 165,545 | ||
| 2025-01-16 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +13,696 | 127,838 | ||
| 2025-01-16 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +29,798 | 157,636 | ||
| 2025-01-16 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award | +10,822 | 168,458 | ||
| 2025-01-16 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion | +54,175 | 239,209 | ||
| 2025-01-16 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award | +101,812 | 341,021 | ||
| 2025-01-16 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit | −54,175 | 0 | ||
| 2025-01-16 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion | +24,348 | 93,199 | ||
| 2025-01-16 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award | +39,730 | 132,929 | ||
| 2025-01-16 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit | −24,348 | 0 | ||
| 2025-01-08 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −6,223 | $175.30 | $1.1M | 199,804 |
| 2025-01-02 | Sheena Jonathan Director | Sale 10b5-1 | −1,230 | $158.71 | $195K | 255,842 |
| 2025-01-02 | Sheena Jonathan Director | Sale 10b5-1 | −900 | $159.65 | $144K | 254,942 |
| 2025-01-02 | Sheena Jonathan Director | Sale 10b5-1 | −570 | $160.67 | $92K | 254,372 |
| 2025-01-02 | Sheena Jonathan Director | Sale 10b5-1 | −641 | $158.74 | $102K | 45,641 |
| 2025-01-02 | Sheena Jonathan Director | Sale 10b5-1 | −555 | $159.69 | $89K | 45,086 |
Page 59 of 85 · 1,682 trades